title: Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.
abstract: ICP (intrahepatic cholestasis of pregnancy) is characterized by pruritus and biochemical cholestasis, including raised SBAs (serum bile acids) and, usually, elevated aminotransferases levels. However, AHP (asymptomatic hypercholanaemia of pregnancy) is defined as the presence of total SBA levels above the cut-off value (11 microM) in healthy pregnant women, thus elevation of total SBAs do not necessarily reflect an ICP condition. The aim of the present study was to describe clinical, obstetric, perinatal and biochemical findings, as well as the SBA profile, in pregnant women studied in the third trimester of pregnancy in order to define characteristic patterns of individual bile acids that enable women with ICP to be distinguished from AHP and healthy pregnancies. Free and conjugated ursodeoxycholic (UDCA), cholic (CA), lithocholic (LCA), deoxycholic (DCA) and chenodeoxycholic (CDCA) acids were evaluated by CE (capillary electrophoresis) in 41 patients (15 of them simultaneously by HPLC), in 30 healthy pregnant women and in 10 non-pregnant women. A highly significant correlation between CE and HPLC for total SBAs (r=0.990) and for individual SBAs was found. Normal pregnant women had higher total SBA levels than non-pregnant women (due to an increase in taurine-conjugated dihydroxy SBAs). Women with ICP had higher levels of total SBAs, the free/conjugated ratio, LCA, CA, CDCA and DCA than normal pregnant women. Newborns from women with ICP had lower birth weight and gestational age. Women with AHP had higher levels of conjugated dihydroxy SBAs than normocholanaemic patients, without any evidence of a clinical difference. In conclusion, the present study has shown a clear difference in SBA profiles between ICP and normal pregnancies (including AHP), involving a shift towards a characteristic hydrophobic composition in women with ICP.
authors.affiliation: Gastroenterology Section, Department of Internal Medicine, Hospital J. M. Penna, Buenos Aires, Argentina.
authors.forename: Gustavo
authors.initials: G
authors.lastname: Castaño
authors.forename: Silvia
authors.initials: S
authors.lastname: Lucangioli
authors.forename: Silvia
authors.initials: S
authors.lastname: Sookoian
authors.forename: Marcelo
authors.initials: M
authors.lastname: Mesquida
authors.forename: Abraham
authors.initials: A
authors.lastname: Lemberg
authors.forename: Mirta
authors.initials: M
authors.lastname: Di Scala
authors.forename: Paula
authors.initials: P
authors.lastname: Franchi
authors.forename: Clyde
authors.initials: C
authors.lastname: Carducci
authors.forename: Valeria
authors.initials: V
authors.lastname: Tripodi
mesh_terms: D000328:Adult; D001647:Bile Acids and Salts / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001724:Birth Weight; D016022:Case-Control Studies; D002635:Chenodeoxycholic Acid / Q000097:blood; D016009:Chi-Square Distribution; D002780:Cholestasis, Intrahepatic / Q000097:blood / Q000175:diagnosis*; D019826:Cholic Acid / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D003430:Cross-Sectional Studies; D003840:Deoxycholic Acid / Q000097:blood; D019075:Electrophoresis, Capillary; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008095:Lithocholic Acid / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D014580:Ursodeoxycholic Acid / Q000097:blood
chemical_list: D001647:Bile Acids and Salts; D015415:Biomarkers; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D008095:Lithocholic Acid; D014580:Ursodeoxycholic Acid; D019826:Cholic Acid